ARCHIVES

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

This article is from The Cancer Letter archive.

Vol. 39 No. 17 | April 25, 2013

Download PDF Visit The Full Archive

Related Articles

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974